NCM
LLY icon

Novare Capital Management’s Eli Lilly LLY Stock Holding History

Novare Capital Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.4M Sell
9,543
-372
-4% -$380K 0.81% 44
2026
Q1 		$9.12M Buy
9,915
+4,799
+94% +$4.87M 0.72% 52
2025
Q4 		$5.5M Buy
5,116
+989
+24% +$946K 0.41% 62
2025
Q3 		$3.15M Buy
4,127
+127
+3% +$94.5K 0.24% 73
2025
Q2 		$3.12M Buy
4,000
+2,131
+114% +$1.66M 0.25% 76
2025
Q1 		$1.54M Buy
1,869
+1,282
+218% +$1.07M 0.13% 103
2024
Q4 		$453K Buy
587
+60
+11% +$49.7K 0.04% 140
2024
Q3 		$467K Buy
527
+225
+75% +$202K 0.04% 140
2024
Q2 		$273K Sell
302
-12
-4% -$9.6K 0.02% 156
2024
Q1 		$244K Buy
+314
New +$223K 0.02% 167

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Novare Capital Management's LLY Position: Q2 2026 in Review

Novare Capital Management reduced its Eli Lilly (LLY) stake by 3.8% in Q2 2026, selling an estimated $380K and leaving 9,543 shares worth $11.4M. The position accounts for 0.81% of the portfolio, ranked #44.

Novare Capital Management first reported a position in LLY in Q1 2024 and has held it in 10 quarters since. 4,630 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Novare Capital Management held 9,543 shares of Eli Lilly worth $11.4M as of Q2 2026.
  • Novare Capital Management sold 372 Eli Lilly shares in Q2 2026, an estimated $380K.
  • Eli Lilly made up 0.81% of Novare Capital Management's portfolio in Q2 2026, its #44 holding.
  • Novare Capital Management first reported a position in Eli Lilly in Q1 2024 and has held it in 10 quarters since.
  • 4,630 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Novare Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.